Tetra Bio-Pharma Cash Flow Statement

Financials in millions CAD. Fiscal year is December - November.

Millions CAD. Fiscal year is Dec - Nov.

Fiscal Year	TTM	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	2014 - 2016
Period Ending	Aug '22 Aug 31, 2022	Nov '21 Nov 30, 2021	Nov '20 Nov 30, 2020	Nov '19 Nov 30, 2019	Nov '18 Nov 30, 2018	Nov '17 Nov 30, 2017	2014 - 2016
Net Income	-39.02	-52.18	-26.48	-15.28	-7.57	-6.23	Upgrade
Depreciation & Amortization	0.1	0.11	0.03	0.03	-	0.01	Upgrade
Loss (Gain) From Sale of Assets	-	-	-	-	-4.23	-	Upgrade
Asset Writedown & Restructuring Costs	23.98	23.98	0.4	-	-	-	Upgrade
Loss (Gain) From Sale of Investments	1.56	1.24	-	-	-	-	Upgrade
Loss (Gain) on Equity Investments	0.65	0.95	0.27	-	-	-	Upgrade
Stock-Based Compensation	0.26	1.05	0.57	0.23	1.43	2.31	Upgrade
Other Operating Activities	0.11	0.11	5.32	2.2	-0.27	-0.19	Upgrade
Change in Accounts Receivable	0.4	0.4	-0.36	0.47	-0.57	-0.13	Upgrade
Change in Inventory	-	-	-	-	0.04	-0.04	Upgrade
Change in Accounts Payable	3.9	-0.56	2.84	-0.79	2.04	0.35	Upgrade
Change in Other Net Operating Assets	-0.13	-0.38	-0.29	0.31	-0.39	0.03	Upgrade
Operating Cash Flow	-8.18	-25.28	-19.64	-17.34	-9.51	-3.89	Upgrade
Capital Expenditures	-0.01	-0.34	-0.24	-0.25	-	-	Upgrade
Cash Acquisitions	-	-	-	-3.43	-2.48	-	Upgrade
Divestitures	-	-	-	-	0.35	-	Upgrade
Sale (Purchase) of Intangibles	-0.02	-0.82	-1.91	-	-	-0.75	Upgrade
Investment in Securities	-0.65	-0.97	-1.26	-	-	-	Upgrade
Investing Cash Flow	-0.68	-2.12	-3.42	-3.69	-2.13	-0.75	Upgrade
Long-Term Debt Issued	-	3	-	-	-	-	Upgrade
Total Debt Issued	-	3	-	-	-	-	Upgrade
Short-Term Debt Repaid	-	-2	-	-	-	-	Upgrade
Total Debt Repaid	-1.45	-2	-	-	-	-	Upgrade
Net Debt Issued (Repaid)	-1.45	1	-	-	-	-	Upgrade
Issuance of Common Stock	2.63	31.45	27.04	8.61	24.63	5.62	Upgrade
Other Financing Activities	-0.4	-2.67	-3.52	1.12	-1.59	-0.01	Upgrade
Financing Cash Flow	0.78	29.78	23.52	9.73	23.03	5.62	Upgrade
Net Cash Flow	-8.09	2.39	0.46	-11.3	11.39	0.97	Upgrade
Free Cash Flow	-8.2	-25.61	-19.88	-17.6	-9.51	-3.89	Upgrade
Free Cash Flow Per Share	-0.02	-0.06	-0.08	-0.09	-0.07	-0.04	Upgrade
Levered Free Cash Flow	-3.52	-16.79	-11.26	-9.2	-4.71	-2.44	Upgrade
Unlevered Free Cash Flow	-3.21	-15.6	-11.26	-9.2	-4.71	-2.44	Upgrade
Change in Working Capital	4.17	-0.54	2.18	-0.01	1.14	0.2	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.